Search Reports :

Global Vaccine Market Outlook (2007-2010)

Share |
Publish Date:  Nov, 2007   New Report Available No. of Pages: 135
Format: Adobe Reader (PDF) Upto 24 hour delivery
Global Vaccine Market Outlook (2007-2010)
  Electronic Access - Single User License   US$ 1600.00
  CD-ROM Mail Delivery   US$ 1900.00
  Hard Copy Mail Delivery   US$ 1900.00
  Electronic Access - Multi-User License   US$ 2200.00
Description Table of Content
List of Figures & Tables

List of Figures:

Figure 3-1: Vaccines Horizon* (1960 to 2010)
Figure 4-1: Global - Vaccine Market (in Billion US$), 2003-2006E
Figure 4-2: Global - Forecast for Vaccine Market (in Billion US$), 2007-2010
Figure 5-1: Global - Vaccine Market Segmentation by Region (%), 2005
Figure 5-2: Global - Sales Split of Major Vaccine Player by Region (%), 2004
Figure 5-3: US - Vaccine Market (in Billion US$), 2003, 2006E, 2008E & 2013E
Figure 5-4: US - Pediatric Vaccine Market (in Billion US$), 2003, 2006E, 2008E & 2013E
Figure 5-5: US - Hepatitis Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-6: US - Biodefense Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-7: US - Influenza Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-8: US - Travel Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-9: US - Developmental Vaccine Market (in Million US$), 2008E & 2013E
Figure 5-10: Europe - Vaccine Market (in Billion US$), 2005, 2006E, 2008E & 2012E
Figure 5-11: Japan - Influenza Vaccine Production (in Million Units), 2004-05, 2005-06 & 2006-07E
Figure 5-12: China - Vaccine Market (in Billion RMB) 2004-2006E
Figure 5-13: China - Forecast for Vaccine Market (in Billion RMB) 2007-2010
Figure 5-14: India - Vaccine Market (in Million US$) 2004-05 to 2008-09E
Figure 5-15: India - Share of Public & Private Sectors in Vaccine Market (%), Nov 2006
Figure 5-16: India - Top 6 Selling Drugs in Vaccine Market (in Rs Crore), 2005-06
Figure 5-17: India - Share of Domestic Consumption & Exports in Vaccine Market (%), 2005-06
Figure 5-18: Brazil - Vaccine Market (in Million BRL), 2000, 2004, 2006E & 2008E
Figure 5-19: Brazil - Share of Public & Private Sectors in Vaccine Market (%), 2000
Figure 5-20: Global - Vaccine Market by Segment (in Billion US$), 2005, 2006E & 2010E
Figure 5-21: Global - Share of Vaccine Market by Segment (%), 2005, 2006E & 2010E
Figure 5-22: Global - Basic Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-23: Global - Forecast for Basic Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-24: Global - Enhanced Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-25: Global - Forecast for Enhanced Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-26: Global - Proprietary Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-27: Global - Forecast for Proprietary Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-28: Global - Adult/Travel Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-29: Global - Forecast for Adult/Travel Vaccine Market (in Billion US$), 2007-2010
Figure 5-30: Global - Therapeutics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-31: Global - Forecast for Therapeutics Vaccine Market (in Billion US$), 2007-2010
Figure 5-32: Global - Cancer Vaccine Market (in Billion US$), 2005, 2008E & 2010E
Figure 5-33: Global - Addiction Vaccine Market (in Million US$), 2008E & 2010E
Figure 5-34: Global - Influenza Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-35: Global - Share of Influenza Vaccine Production by Manufacturer (%), 2006
Figure 5-36: Global - Forecast for Influenza Vaccine Market (in Billion US$), 2007-2010
Figure 6-1: Global - Pneumococcal Vaccine Market (in Billion US$), 2006 & 2010E
Figure 6-2: Global - Number of Polio Incidences (2004-2006)
Figure 6-3: Global - Countries with Maximum Number of Polio Incidences, 2006
Figure 6-4: Global - Polio Vaccine Market (in Million US$), 2004 & 2011E
Figure 6-5: Global - Inactivated Polio Vaccine Doses (in Million), 2006 & 2011F
Figure 6-6: Global - Meningitis Vaccine Market (in Billion US$), 2004 & 2010E
Figure 6-7: Global - Forecast for Rotavirus Vaccine Market (in Billion US$), 2010
Figure 6-8: Global - Forecast for Rotavirus Vaccine Market Segmentation by Region (%), 2010
Figure 6-9: Global - Number of Diphtheria Incidences by Region, 2006
Figure 6-10: Global - Number of Pertussis Incidences by Region, 2006
Figure 6-11: Global - Number of nTetanus Incidences by Region, 2006
Figure 6-12: Global - Number of tTetanus Incidences by Region, 2006
Figure 6-13: Global - Share of DTP Combos Market by Player (%), 2004
Figure 6-14: Global - Number of Measles Incidences by Region, 2006
Figure 6-15: Global - Number of Mumps Incidences by Region, 2006
Figure 6-16: Global - Number of Rubella Incidences by Region, 2006
Figure 6-17: Global - Number of Tuberculosis Incidences (in Thousand), 2005
Figure 7-1: Global - Hepatitis B Surface Antigen Prevalence (%), 2005
Figure 7-2: Global - Hepatitis B Vaccine Market (in Million US$), 1999, 2005, 2006 & 2011F
Figure 8-1: Global - Profit Margins of Vaccines, Generics & Branded Drugs (%), 2007E
Figure 8-2: Global - Sources of Financing for Vaccine Market (%), 2001
Figure 8-3: Global - Prevnar Sales (in Million US$), 2003-2006
Figure 8-4: US - Drug Discovery Contract Research Organization Market (in Billion US$), 2006E & 2013E
Figure 8-5: Global - Dose Consumption & Revenue by Income of Region (%), 2005
Figure 9-1: Global - Share of Vaccine Market by Player (%), 2005 
 
List of Tables:  

Table 5-1: China - Vaccine Classification
Table 5-2: China - Pediatric Vaccine Requirement (in Million Doses)
Table 5-3: Brazil - Public & Private Sectors Vaccine Market (in Million BRL), 2000
Table 7-1: Global - Number of HIV/AIDS Patients (in Million), 2006
Table 8-1: Global - Number of Deaths due to Diphtheria Averted by Vaccines (in Thousand), 2001
Table 8-2: Global - Cumulative Confirmed Human Cases & Number of Deaths due to Avian Influenza A/ (H5N1), 2003-2007
Table 9-1: Global - Share of Vaccines in Total Pharma Sales of Major Players (%), 2005
Table 9-2: Global - Growth of Vaccines Segment of Major Pharma Players (%), 2005
Table 9-3: Global - Overall Growth of Major Pharma Players (%), 2005
Table 9-4: Global - Major Vaccine Companies (Segmentation by Revenue)
Table 9-5: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
Table 9-6: GlaxoSmithKline Plc. - Key Financials (in Million US$), 2004-2006
Table 9-7: Merck & Co., Inc. - Key Financials (in Million US$), 2004-2006
Table 9-8: Novartis - Key Financials (in Million US$), 2004-2006
Table 9-9: Wyeth - Key Financials (in Million US$), 2004-2006

Not able to find data you are looking for? Ask our Research Analyst.

All Research Reports

- Healthcare Industry (46)

   - Pharma (16)

   - Biotech (7)

   - Healthcare (17)

   - Vaccine (2)

   - Generics (4)

 

Related Reports

- Insulin Delivery Systems ...
- Booming Clinical Trials M...
- World Pharmaceutical Mark...
 
Related Research News
Jan 25, 2010
Dec 30, 2009
Nov 15, 2009
Oct 21, 2009
Related Press Releases
Mar 10, 2010
Feb 25, 2010
Jan 02, 2010
Oct 09, 2009
Email Subscription
Receive email alerts of new market research report in your industry.

Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL
Copyright © 2010, RNCOS, 2002-2010
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707